The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.2058iti3
The Journal of Experimental Medicine, Vol. 205, No. 8, 1717-
The Rockefeller University Press, 0022-1007 $30.00
© Bashyam
This Article
Right arrow Full Text (PDF, 1387K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

IN THIS ISSUE

Twisted control


Figure 1
Knockdown of twist1 increases the production of TNF (red) in the arthritic joints of mice.

Over-stimulated T helper (Th)-1 cells keep themselves in check by activating an internal brake, say Niesner et al. (page 1889).

Th1 cells activated by self-antigens can cause chronic inflammation, as seen in autoimmune diseases such as diabetes and rheumatoid arthritis. Niesner et al. were searching for genes that are highly expressed in such chronically activated Th1 cells in mice and discovered a transcriptional repressor called twist1. Now, the authors show that repeatedly activated Th1 cells avoid turning deadly by turning on twist1, which then inhibits NF-{kappa}B–dependent cytokine production.

Absent in naive mouse T cells, twist1 was switched on when these cells were stimulated with antigen in the presence of the Th1 polarizing cytokine IL-12 but not the Th2 cytokine IL-4. IL-12 activates the transcriptional activator STAT4, which then bound to and activated the twist1 promoter. Subsequent antigen stimulation increased twist1 expression in the Th1 cells, dampening their inflammatory cytokine production. The delayed induction of twist1 probably gives Th1 cells a chance to initiate inflammation before they are shut down.

An infusion of twist1-deficient Th1 cells worsened arthritis in mice, whereas a shot of Th1 cells overexpressing twist1 ameliorated disease. Before this finding can be clinically exploited, a twist in the human twist1 story needs to be sorted out: Th1 cells found in the diseased tissues of patients suffering from arthritis or chronic gut inflammation had plenty of twist1. Whether human twist1 also acts as a brake and, if so, how these disease-associated Th1 cells bypass it remains to be seen.



Hema Bashyam

hbashyam{at}rockefeller.edu



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 1387K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS